|
|
On Wednesday, September 25, 2019, Peyton Manning Children’s Hospital hosted its 20th Annual Pediatric CME Conference at the Ritz Charles Banquet and Conference Center.
This one-day conference provides primary care providers with the opportunity to further their education and encourages new skills in relevant, evidenced-based pediatric topics. It also includes vendor exhibits and opportunities to network with community organizations that serve children.
This year’s keynote speaker was Anders Kolb, MD who presented the session titled “Progress and Possibilities in Childhood Acute Myeloid Leukemia.” Dr. Kolb is the Director of the Center for Cancer and Blood Disorders at Nemours/Alfred I. duPont Hospital for Children in Wilmington, Delaware, and member of the Children’s Oncology Group (COG) Scientific Council. As a founding member of the National Cancer Institute funded Pediatric Preclinical Testing Program, he has successfully completed preclinical evaluations of numerous anti-cancer strategies in human tissues and aided in the translation of these agents into clinical trials. His expertise is in genomics, proteomics and cell signaling research to support the critical rationale needed for effective translational medicine. Within the Children’s Oncology Group (COG), Dr. Kolb serves as the Chair of the Myeloid Disease Committee and Member of the Scientific Council. Through this work, his focus is on collaborative science, resource stewardship, clinical research development, clinical trial design and implementation, and in the necessities new agent development.
Dr. Kolb’s visit and presentation were made possible by a generous donor.
|